All Outcomes

Show Outline
Top   Main   All Outcomes
Home   COVID-19 treatment studies for Ensovibep  COVID-19 treatment studies for Ensovibep  C19 studies: Ensovibep  Ensovibep   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
Supplementary Data — Ensovibep for COVID-19: real-time meta analysis of 2 studies
Covid Analysis, May 2023
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Novartis (RCT) 89% 0.11 [0.01-2.27] death 0/301 2/99 Improvement, RR [CI] Treatment Control Novartis (RCT) 87% 0.13 [0.03-0.67] hosp. 2/301 5/99 Novartis (RCT) 78% 0.22 [0.06-0.76] hosp./ER 4/301 6/99 ACTIV-3/TICO Barkauskas (DB RCT) 17% 0.83 [0.51-1.35] death 30/247 35/238 ACTIV-3/TICO Barkauskas (DB RCT) 6% 0.94 [0.78-1.14] no recov. 44/247 48/238 ACTIV-3/TICO Barkauskas (DB RCT) -8% 1.08 [0.77-1.49] no recov. 247 (n) 238 (n) ACTIV-3/TICO Barkauskas (DB RCT) 7% 0.93 [0.78-1.11] no disch. 28/247 34/238 Ensovibep COVID-19 outcomes May 2023 Favors ensovibep Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop